MK-8245 Trifluoroacetate

• CAT Number: I001584
• CAS Number: 1415559-41-9
• Molecular Formula: C19H17BrF4N6O6
• Molecular Weight: 581.27
• Purity: ≥95%
• Synonyms: 2-[5-[3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2-oxazol-5-yl]tetrazol-2-yl]acetic acid; 2,2,2-trifluoroacetic acid
• Target: Stearoyl-CoA Desaturase (SCD)
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• IC50: 1 nM (hSCD1)
• IUPAC Name: 2-[5-[3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2-oxazol-5-yl]tetrazol-2-yl]acetic acid;2,2,2-trifluoroacetic acid
• InChI: InChI=1S/C17H16BrFN6O4.C2HF3O2/c18-12-2-1-10(19)7-13(12)28-11-3-5-24(6-4-11)15-8-14(29-22-15)17-20-23-25(21-17)9-16(26)27;3-2(4,5)1(6)7/h1-2,7-8,11H,3-6,9H2,(H,26,27);(H,6,7)
• InChIKey: LEBPCMXFQYATAK-UHFFFAOYSA-N
• SMILES: C1CN(CCC1OC2=C(C=CC(=C2)F)Br)C3=NOC(=C3)C4=NN(N=N4)CC(=O)O.C(=O)(C(F)(F)F)O

MK-8245 Trifluoroacetate（Cat No.:I001584）is a selective inhibitor of a specific enzyme or molecular target, investigated for its potential therapeutic applications, particularly in the context of oncology or other diseases related to aberrant cellular signaling. This compound is part of ongoing research, aiming to understand its effects on cancer cell proliferation, survival, and metastasis. By inhibiting key pathways or proteins, MK-8245 Trifluoroacetate may offer targeted treatment options with fewer side effects compared to conventional therapies. Clinical studies are underway to evaluate its safety, pharmacokinetics, and efficacy in treating cancers or other related conditions.